SNY and SASY Related Headlines
Go Back- Citi initiates coverage of European pharma stocks; AstraZeneca 'best in class'
- M. Stanley cuts Novo Nordisk to Underweight on ’tough path ahead’, shares slip
- AstraZeneca says Fasenra misses main goal in COPD trial

